|Bid||3.8900 x 3200|
|Ask||3.9200 x 1100|
|Day's Range||3.8500 - 3.9400|
|52 Week Range||3.6000 - 10.9800|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds’ and investors’ portfolio positions as of September 30th. In this article, we look at what those funds think of ProQR Therapeutics NV (NASDAQ:PRQR) based on that […]
Daniel de Boer has been the CEO of ProQR Therapeutics N.V. (NASDAQ:PRQR) since 2012, and this article will examine the...
ProQR (PRQR) delivered earnings and revenue surprises of -33.33% and -100.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?